# US 2013/0274452 A1 · Cyanine dyes and their conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0274452 A1
- Document ID: US20130274452A1
- Status: Published application
- Kind: A1
- Application number: 13/831,345
- Filed: 2013-03-14
- Published: 2013-10-17
- Earliest claimed: 2010-10-20
- Assignees: LI-COR, Inc.
- Applicants: Li-Cor, Inc.
- Inventors: Xinshe Xu; Daniel R. Draney; Lael Cheung
- Web page: https://patentgrep.com/patent/US20130274452A1

## CPC

- A61K 49/0058: {Antibodies}
- A61K 49/0032: {Methine dyes, e.g. cyanine dyes}
- A61K 49/0052: {Small organic molecules (oligomers, polymers, dendrimers A61K49/0054)}
- C07D 471/04: Ortho-condensed systems
- C07F 9/6561: containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07K 19/00: Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}
- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- C09B 23/0008: {substituted on the polymethine chain}
- C09B 23/0016: {the substituent being a halogen atom}
- C09B 23/0025: {the substituent being bound through an oxygen atom}
- C09B 23/0066: {the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)}
- C09B 23/083: {five >CH- groups}
- C09B 23/086: {more than five >CH- groups}
- C09B 69/00: Dyes not provided for by a single group of this subclass
- G01N 33/575: for cancer
- G01N 33/58: involving labelled substances (G01N33/53 takes precedence)
- G01N 33/582: {with fluorescent label}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Compounds and methods are disclosed that are useful for noninvasive imaging in the near-infrared spectral range. The cyanine compounds of Formula I are presented: wherein Q is a portion of a polymethine bridge selected from the group consisting of: Also included are bioconjugates of the compounds of Formula I, methods of labeling biomolecules with the compounds, and methods of imaging.

## Claims

### Claim 1

A compound of Formula I:
wherein
Q is a portion of a polymethine bridge selected from the group consisting of:
wherein Q is the central portion of either a five- or a seven-polymethine-carbon polymethine bridge;
each R1 is a member independently selected from the group consisting of -L-Y—Z and an alkyl that is additionally substituted with from 0 to 1 R13 and from 0 to 1 R16, wherein the alkyl is optionally interrupted by at least one heteroatom;
each R2a and R2b is a member independently selected from the group consisting of alkyl, alkenyl, hydroxyalkyl, alkoxyalkyl, aminoalkyl, amidoalkyl, alkylthioalkyl, carboxyalkyl, alkoxycarbonylalkyl, or sulfonatoalkyl; wherein a carbon of the member is additionally substituted with from 0 to 1 R16; or, alternatively, a R2a and R2b pair, together with the ring carbon to which the R2a and R2b are bonded, join to form a spirocycloalkyl ring, wherein the spirocycloalkyl ring is additionally substituted with from 0 to 6 R14 and from 0 to 1 R16, or an exocyclic alkene, wherein the exocyclic alkene is additionally substituted with from 0 to 2 R14 and from 0 to 1 R16;
each R3, R4a, R4b, R5a, R5b, R6a, and R6b is a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, hydroxyl, alkoxy, amino, cyano, carboxyl, alkoxycarbonyl, amido, sulfonato, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, and sulfonatoalkyl; wherein a carbon of the member is additionally substituted with from 0 to 1 R16; or, alternatively, a pair of said members that is selected from the group consisting of R3 and R4a, an R4a and R5a, and an R5a and R6a, together with the pair of atoms to which the pair of said members is bonded, joins to form an aryl ring, wherein the aryl ring is additionally substituted with from 0 to 2 R14 and from 0 to 1 R16;
each R7 is a member independently selected from the group consisting of hydrogen and alkyl; wherein the alkyl is additionally substituted with from 0 to 3 R14 and from 0 to 1 R16; or, alternatively, both R7, together with the intervening segment of the polyene to which both R7 are bonded, join to form a ring, wherein said ring is selected from the group consisting of a cycloalkyl and a heterocyclyl ring; wherein the ring is additionally substituted with from 0 to 3 R14 and from 0 to 1 R16;
R8, R9, R10, R11 and R12 are each a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, alkoxy, sulfonato, sulfonatoalkyl, hydroxyl, amino, carboxyl, alkoxycarbonyl, cyano, amido, thioacetyl, and -L-Y—Z; wherein, if present, at least one member selected from the group consisting of R8, R9, and R19 is -L-Y—Z;
each R13 is a member independently selected from the group consisting of hydroxyl, amino, carboxyl, alkoxycarbonyl, cyano, amido, sulfonato, and thioacetyl;
each R14 is a member independently selected from the group consisting of alkyl, alkenyl, halo, hydroxyl, alkoxy, amino, cyano, carboxyl, alkoxycarbonyl, amido, sulfonato, alkoxycarbonylalkyl, and alkoxyalkyl; wherein the alkyl or alkenyl is additionally substituted with from 0 to 1 R13 and from 0 to 1 R16;
each L is an optional member independently selected from the group consisting of a bond, a C1-C20 alkylene, and a C1-C20 alkenylene; wherein the alkylene or alkenylene is optionally interrupted by at least one heteroatom;
each Y is an optional member independently selected from the group consisting of a bond, —O—, —S—, —NH—, —NHC(O)—, —C(O)NH—, —NR15—, —NR15C(O)—, —C(O)NR15—, —N(Z)—, —N(Z)C(O)—, and —C(O)N(Z)—;
each Z is independently selected from the group consisting of -L-R13 and -L-R16, alternatively, —Y—Z is a member selected from the group consisting of —N(Z)2, —N(Z)C(O)Z, and —C(O)N(Z)2, and the two Z groups may optionally be linked to form a cycloalkynyl group;
each R15 is a member independently selected from the group consisting of alkyl and alkoxycarbonylalkyl, wherein the alkyl is optionally interrupted by at least one heteroatom;
each R16 is independently a member selected from the group consisting of activated acyl, acrylamido, optionally substituted alkylsulfonate ester, azido, optionally substituted arylsulfonate ester, optionally substituted amino, aziridino, boronato, cycloalkynyl, cycloalkynylcarbonyl, diazo, formyl, glycidyl, halo, haloacetamidyl, haloalkyl, haloplatinato, halotriazino, hydrazinyl, imido ester, isocyanato, isothiocyanato, maleimidyl, mercapto, phosphoramidityl, a photoactivatable moiety, vinyl sulfonyl, alkynyl, cycloalkynyl, spirocycloalkynyl, a pegylated azido, a pegylated alkynyl, a pegylated cycloalkynyl, a pegylated spirocycloalkynyl, an ortho substituted phosphinyl aryl ester, and an ortho substituted phosphine oxide aryl ester; and
wherein said compound has a balanced charge.

### Claim 2 (depends on 1)

The compound of claim 1, wherein each R16 is independently a member selected from the group consisting of activated acyl, acrylamido, optionally substituted alkylsulfonate ester, azido, optionally substituted arylsulfonate ester, amino, aziridino, boronato, diazo, formyl, glycidyl, halo, haloacetamidyl, haloalkyl, haloplatinato, halotriazino, hydrazinyl, imido ester, isocyanato, isothiocyanato, maleimidyl, mercapto, phosphoramidityl, a photoactivatable moiety, and vinyl sulfonyl.

### Claim 3 (depends on 2)

The compound of claim 2, wherein when —Y—Z is a member selected from the group consisting of —N(Z)2, —N(Z)C(O)Z, and —C(O)N(Z)2, the two Z groups are not linked to form a cycloalkynyl group.

### Claim 4 (depends on 1)

The compound of claim 1, wherein at least one R16 is independently a member selected from the group consisting of azido, alkynyl, cycloalkynyl, a pegylated azido, a pegylated alkynyl, a pegylated cycloalkynyl and an ortho substituted phosphinyl aryl ester.

### Claim 5 (depends on 1)

The compound of claim 1, wherein each R1 is independently an alkyl that is additionally substituted with from 0 to 1 R13 and from 0 to 1 R16, wherein the alkyl is optionally interrupted by at least one heteroatom.

### Claim 6 (depends on 2)

The compound of claim 2, wherein Q is selected from the group consisting of:

### Claim 7 (depends on 2)

The compound of claim 2, wherein Q is selected from the group consisting of:

### Claim 8 (depends on 1)

The compound of claim 1, wherein each R3, R4a, R4b, R5a, R5b, R6a, and R6b is a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, alkoxy, cyano, carboxyl, alkoxycarbonyl, amido, sulfonato, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, and sulfonatoalkyl.

### Claim 9 (depends on 6)

The compound of claim 6, wherein Q is

### Claim 10 (depends on 1)

The compound of claim 1, wherein R2a and R2b are methyl.

### Claim 11 (depends on 1)

The compound of claim 1, wherein R1 is (CH2)rSO3H or (CH2)rSO3—; and
wherein r is an integer from 1 to 20.

### Claim 12 (depends on 11)

The compound of claim 11, wherein r is 2, 3, or 4.

### Claim 13 (depends on 1)

The compound of claim 1, wherein -L-Y— is (CH2)t;
wherein Z is carboxyl or activated acyl; and
wherein t is an integer from 0 to 10.

### Claim 14 (depends on 2)

The compound of claim 2, wherein R8 is -L-Y—Z.

### Claim 15 (depends on 14)

The compound of claim 14, wherein R9, R10, R11, and R12 are each a member independently selected from the group consisting of hydrogen, alkyl, halo, sulfonato, and sulfonatoalkyl.

### Claim 16 (depends on 2)

The compound of claim 2, wherein R10 is -L-Y—Z.

### Claim 17 (depends on 16)

The compound of claim 16, wherein R9, R10, R11, and R12 are each a member independently selected from the group consisting of hydrogen, alkyl, halo, sulfonato, and sulfonatoalkyl.

### Claim 18 (depends on 2)

The compound of claim 2, wherein R9 is -L-Y—Z.

### Claim 19 (depends on 18)

The compound of claim 18, wherein R8, R10, R11, and R12 are each a member independently selected from the group consisting of hydrogen, alkyl, halo, sulfonato, and sulfonatoalkyl.

### Claim at position 20

20-47. (canceled)

### Claim 48 (depends on 47)

The compound of claim 47, having the formula:
wherein M is a cationic counterion.

### Claim 49 (depends on 48)

The compound of claim 48, having the formula:

### Claim 50 (depends on 48)

The compound of claim 48, having the formula:

### Claim at position 24

51-68. (canceled)

### Claim 69

A bioconjugate compound of Formula II:
wherein
QL is a portion of a polymethine bridge selected from the group consisting of:
wherein QL is the central portion of either a five- or a seven-polymethine-carbon polymethine bridge;
each R1 is a member independently selected from the group consisting of -L-Y—Z and alkyl that is additionally substituted with from 0 to 1 R13 and from 0 to 1 RL; wherein the alkyl is optionally interrupted by at least one heteroatom;
each R2a and R2b is a member independently selected from the group consisting of alkyl, alkenyl, hydroxyalkyl, alkoxyalkyl, aminoalkyl, amidoalkyl, alkylthioalkyl, carboxyalkyl, alkoxycarbonylalkyl, or sulfonatoalkyl; wherein a carbon of the member is additionally substituted with from 0 to 1 RL; or, alternatively, a R2a and R2b pair, together with the ring carbon to which the R2a and R2b are bonded, join to form a spirocycloalkyl ring, wherein the spirocycloalkyl ring is additionally substituted with from 0 to 6 R14 and from 0 to 1 RL, or an exocyclic alkene, wherein the exocyclic alkene is additionally substituted with from 0 to 2 R14 and from 0 to 1 RL;
each R3, R4a, R4b, R5a, R5b, R6a, and R6b is a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, hydroxyl, alkoxy, amino, cyano, carboxyl, alkoxycarbonyl, amido, sulfonato, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, and sulfonatoalkyl; wherein a carbon of the member is additionally substituted with from 0 to 1 RL; or, alternatively, a pair of said members that is selected from the group consisting of R3 and R4a, an R4a and R5a, and an R5a and R6a, together with the pair of atoms to which the pair of said members is bonded, joins to form an aryl ring, wherein the aryl ring is additionally substituted with from 0 to 2 R14 and from 0 to 1 RL;
each R7 is a member independently selected from the group consisting of hydrogen and alkyl; wherein the alkyl is additionally substituted with from 0 to 3 R14 and from 0 to 1 RL; or, alternatively, both R7, together with the intervening segment of the polyene to which both R7 are bonded, join to form a ring, wherein said ring is selected from the group consisting of a cycloalkyl and a heterocyclyl ring; wherein the ring is additionally substituted with from 0 to 3 R14 and from 0 to 1 RL;
R8, R9, R10, R11 and R12 are each a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, alkoxy, sulfonato, hydroxyl, amino, carboxyl, alkoxycarbonyl, cyano, amido, thioacetyl, and -L-Y—Z; wherein, if present, at least one member selected from the group consisting of R8, R9, and R10 is -L-Y—Z;
each R13 is a member independently selected from the group consisting of hydroxyl, amino, carboxyl, alkoxycarbonyl, cyano, amido, sulfonato, and thioacetyl;
each R14 is a member independently selected from the group consisting of alkyl, alkenyl, halo, hydroxyl, alkoxy, amino, cyano, carboxyl, alkoxycarbonyl, amido, sulfonato, alkoxycarbonylalkyl, and alkoxyalkyl; wherein the alkyl or alkenyl is additionally substituted with from 0 to 1 R13 and from 0 to 1 RL;
each L is an optional member independently selected from the group consisting of a bond, a C1-C20 alkylene, and a C1-C20 alkenylene; wherein the alkylene or alkenylene is optionally interrupted by at least one heteroatom;
each Y is an optional member independently selected from the group consisting of a bond, —O—, —S—, —NH—, —NHC(O)—, —C(O)NH—, —NR15—, —NR15C(O)—, —C(O)NR15—, —N(Z)—, —N(Z)C(O)—, and —C(O)N(Z)—;
each Z is independently selected from the group consisting of -L-R13 and -L-RL;
alternatively, —Y—Z is a member selected from the group consisting of —N(Z)2, —N(Z)C(O)Z, and —C(O)N(Z)2, and the two Z groups may optionally be linked to form a cycloalkynyl group;
each R15 is a member independently selected from the group consisting of alkyl and alkoxycarbonylalkyl, wherein the alkyl is optionally interrupted by at least one heteroatom;
each RL comprises a linking group and a biomolecule connected thereby, wherein the compound comprises at least one RL; and
wherein said compound has a balanced charge.

### Claim at position 26

70-169. (canceled)

### Claim 170 (depends on 1)

A method of labeling a biomolecule, wherein said method comprises reacting a compound of claim 1 with a biomolecule.

### Claim at position 28

171-208. (canceled)
